KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Times Interest Earned (2019 - 2024)

Inovio Pharmaceuticals (INO) has disclosed Times Interest Earned for 6 consecutive years, with -$177.05 as the latest value for Q1 2024.

  • Quarterly Times Interest Earned fell 26.28% to -$177.05 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$632.05 through Dec 2024, down 436.93% year-over-year, with the annual reading at -$632.05 for FY2024, 436.93% down from the prior year.
  • Times Interest Earned hit -$177.05 in Q1 2024 for Inovio Pharmaceuticals, down from -$97.03 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$9.0 in Q1 2020 to a low of -$332.19 in Q2 2022.
  • Historically, Times Interest Earned has averaged -$128.94 across 5 years, with a median of -$118.16 in 2023.
  • Biggest five-year swings in Times Interest Earned: surged 79.3% in 2020 and later plummeted 1429.38% in 2021.
  • Year by year, Times Interest Earned stood at -$27.47 in 2020, then plummeted by 699.62% to -$219.67 in 2021, then grew by 18.76% to -$178.46 in 2022, then soared by 45.63% to -$97.03 in 2023, then tumbled by 82.47% to -$177.05 in 2024.
  • Business Quant data shows Times Interest Earned for INO at -$177.05 in Q1 2024, -$97.03 in Q4 2023, and -$113.41 in Q3 2023.